165 related articles for article (PubMed ID: 12807242)
21. Clinical significance of mucin production in post-irradiated cervical carcinoma.
Cheung NY; Collins RJ; Ngan HY; Wong LC; Ma HK
Arch Gynecol Obstet; 1992; 252(1):1-4. PubMed ID: 1417084
[TBL] [Abstract][Full Text] [Related]
22. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
[TBL] [Abstract][Full Text] [Related]
23. Primary radiotherapy of stage IIA/B-IIIB cervical carcinoma. A comparison of continuous versus sequential regimens.
Mayer A; Nemeskéri C; Petneházi C; Borgulya G; Varga S; Naszály A
Strahlenther Onkol; 2004 Apr; 180(4):209-15. PubMed ID: 15057431
[TBL] [Abstract][Full Text] [Related]
24. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
25. [Large volume stage I and II epidermoid carcinoma of the uterine cervix treated with primary radiotherapy and surgery].
Touboul E; Lefranc JP; Belkacémi Y; Rogel A; Deluen F; Blondon J; Housset M
Contracept Fertil Sex; 1998 Sep; 26(9):674-85. PubMed ID: 9823696
[TBL] [Abstract][Full Text] [Related]
26. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer.
Marnitz S; Köhler C; Füller J; Hinkelbein W; Schneider A
Strahlenther Onkol; 2006 Jan; 182(1):45-51. PubMed ID: 16404520
[TBL] [Abstract][Full Text] [Related]
27. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
[TBL] [Abstract][Full Text] [Related]
28. Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging.
Mayr NA; Yuh WT; Zheng J; Ehrhardt JC; Magnotta VA; Sorosky JI; Pelsang RE; Oberley LW; Hussey DH
AJR Am J Roentgenol; 1998 Jan; 170(1):177-82. PubMed ID: 9423627
[TBL] [Abstract][Full Text] [Related]
29. Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix.
Tan GC; Sharifah NA; Shiran MS; Salwati S; Hatta AZ; Paul-Ng HO
Asian Pac J Cancer Prev; 2008; 9(4):781-4. PubMed ID: 19256776
[TBL] [Abstract][Full Text] [Related]
30. [Ki-67 expression in stage III cervical squamous cell carcinoma and its correlation with sensitivity to chemoradiotherapy].
Cheng S; Wang Z; Wang L; Zhang M
Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):667-70. PubMed ID: 25564056
[TBL] [Abstract][Full Text] [Related]
31. Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.
Dunst J; Kuhnt T; Strauss HG; Krause U; Pelz T; Koelbl H; Haensgen G
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):778-87. PubMed ID: 12788185
[TBL] [Abstract][Full Text] [Related]
32. [Oncological outcomes of combined therapy in patients with cervical carcinoma FIGO stage IIB].
Kornovski Y; Ismail E; Kaneva M
Akush Ginekol (Sofiia); 2012; 51(4):24-9. PubMed ID: 23234022
[TBL] [Abstract][Full Text] [Related]
33. Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.
Roberts KB; Urdaneta N; Vera R; Vera A; Gutierrez E; Aguilar Y; Ott S; Medina I; Sempere P; Rockwell S; Sartorelli AC; Fischer DB; Fischer JJ
Int J Cancer; 2000 Aug; 90(4):206-23. PubMed ID: 10993961
[TBL] [Abstract][Full Text] [Related]
34. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
35. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
36. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
[TBL] [Abstract][Full Text] [Related]
37. Postoperative radiotherapy for patients with invasive cervical cancer following treatment with simple hysterectomy.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 Sep; 33(9):477-81. PubMed ID: 14594942
[TBL] [Abstract][Full Text] [Related]
38. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-control study.
Kinney WK; Alvarez RD; Reid GC; Schray MF; Soong SJ; Morley GW; Podratz KC; Shingleton HM
Gynecol Oncol; 1989 Sep; 34(3):258-62. PubMed ID: 2767517
[TBL] [Abstract][Full Text] [Related]
39. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
Hashmi H; Maqbool A; Ahmed S; Ahmed A; Sheikh K; Ahmed A
J Coll Physicians Surg Pak; 2016 Apr; 26(4):302-5. PubMed ID: 27097702
[TBL] [Abstract][Full Text] [Related]
40. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
